搜索临床试验以:Purinergic P1 Receptor Antagonists
总计9468个结果
-
First Affiliated Hospital of Harbin Medical UniversityRenJi Hospital; Shengjing Hospital; Beijing Anzhen Hospital; Shaanxi Provincial People's Hospital; Wuhan Union Hospital, China 和其他合作者完全的
-
Jiangsu vcare pharmaceutical technology co., LTD完全的
-
First Affiliated Hospital of Harbin Medical University未知
-
Catholic University of the Sacred Heart终止
-
Assistance Publique Hopitaux De Marseille完全的
-
Liverpool University Hospitals NHS Foundation TrustLiverpool Heart and Chest Hospital NHS Foundation Trust; Countess of Chester NHS Foundation... 和其他合作者完全的流血的 | 急性冠状动脉综合征 | 替格瑞洛 | 氯吡格雷 | 新型抗血小板药物英国
-
First Affiliated Hospital of Harbin Medical University完全的
-
Icahn School of Medicine at Mount SinaiDoris Duke Charitable Foundation完全的
-
Sheba Medical Center完全的
-
SanofiBristol-Myers Squibb完全的
-
SanofiBristol-Myers Squibb完全的
-
Deutsches Herzzentrum MuenchenTechnical University of Munich完全的
-
Washington University School of MedicineAstellas Pharma US, Inc.完全的
-
Vanderbilt University Medical Center招聘中
-
Rush University Medical CenterJohn H. Stroger Hospital完全的患有严重慢性肾脏病的患者正在使用应激剂 Regadenoson 对心脏进行核压力测试进行评估美国
-
University of CalgaryNatural Sciences and Engineering Research Council, Canada撤销
-
First Affiliated Hospital of Harbin Medical University完全的
-
Assistance Publique - Hôpitaux de ParisAstraZeneca; Action Research Group完全的
-
Hospital do Coracao完全的急性ST段抬高型心肌梗死 | 心肌梗死血栓溶解秘鲁, 新西兰, 加拿大, 澳大利亚, 巴西, 中国, 阿根廷, 哥伦比亚, 俄罗斯联邦, 乌克兰